Skip to main content
$1.07 $0.03 (2.9%)

04:00 PM EDT on 06/06/23

Co-Diagnostics, Inc. (NASDAQ:CODX)

CAPS Rating: 1 out of 5

Current Price $1.07 Mkt Cap $32.4M
Open $1.03 P/E Ratio -1.04
Prev. Close $1.07 Div. (Yield) $0.00 (0.0%)
Daily Range $1.03 - $1.08 Volume 50,987
52-Wk Range $0.98 - $7.13 Avg. Daily Vol. 142,875

Caps

How do you think NASDAQ:CODX will perform against the market?

Add Stock to CAPS Watchlist

All Players

33 Outperform
33 Underperform
 

All-Star Players

5 Outperform
24 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CODX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

peacemaker01 (54.44)
Submitted April 19, 2020

CODX is a frontrunner in diagnostic tests for covid19.

joaquingrech (97.64)
Submitted March 27, 2020

it may surge now but long term i just don't see it, only 1 product and easy to replicate

NASDAQ:CODX Summary

Fools bullish on NASDAQ:CODX are also bullish on:

Fools bearish on NASDAQ:CODX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CODX.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 5/13/2021 5:42:16 PM : Outperform Start Price: $7.49 NASDAQ:CODX Score: -83.63

Tiny $200M market cap biotech that is already profitable. No debt and 50% margins. Has patented co-primer technology that works with both DNA and RNA. Approx. 50% International sales of Covid 19 PCR test. Pursuing a broad range of clinical testing possibilities including liquid biopsy cancer detection and direct to consumer Covid testing.

Recs

0
Member Avatar Kentuckyfarmer (< 20) Submitted: 1/15/2021 7:22:08 AM : Outperform Start Price: $10.13 NASDAQ:CODX Score: -102.81

Increased revenue in 2020 was due to covid-19 testing and that was just what the company needed to finally become profitable. They have many other test capabilities if Covid-19 tests go away. They are also involved in the agricultural field which is another interesting avenue for growth in the future. Small cap with lots of room to run

Recs

0
Member Avatar TMFbonefish (36.44) Submitted: 1/12/2021 7:09:04 PM : Outperform Start Price: $10.42 NASDAQ:CODX Score: -102.51

Intellectual property that results in better product performance in a fast-growing competitive space is a recipe for getting acquired or being in a position to take share from others. Applications in agriculture are also intriguing.

Leaderboard

Find the members with the highest scoring picks in CODX.

Score Leader

copetom

copetom (37.76) Score: +426.68

Due to the panic over covid-19 I marked it as outperform. Which it did for a few days. I have since sold it, NVAX, INO, and 2 others. Nice profit on NVAX especially.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Toprope101 99.88 3/12/2020 Underperform 5Y $12.76 -91.61% +66.84% +158.45 0 Comment
evergreen5555 68.86 9/5/2017 11/4/2022 Underperform 5Y $5.91 -81.90% +73.95% +155.85 0 Comment
joaquingrech 97.64 3/27/2020 Underperform 5Y $9.19 -88.36% +67.12% +155.48 1 Comment
patatepoil6 99.70 8/30/2017 Underperform 5Y $5.18 -79.34% +74.45% +153.79 0 Comment
budyzerr 67.45 10/2/2017 Underperform 5Y $6.27 -82.93% +69.83% +152.76 0 Comment
downwithpumpers 96.89 8/16/2017 Underperform 5Y $4.87 -78.03% +73.24% +151.27 0 Comment
demeye 94.01 10/4/2017 Underperform 1Y $5.85 -81.70% +68.54% +150.24 0 Comment
RayNobleEsq 99.98 4/21/2020 Underperform 5Y $13.46 -92.05% +55.39% +147.44 0 Comment
King2061x 50.92 8/7/2017 Underperform 5Y $4.24 -74.76% +72.57% +147.34 0 Comment
onthewallst 76.28 8/2/2017 Underperform 5Y $4.02 -73.38% +72.59% +145.97 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CODX.